Prefoldin prevents aggregation of α-synuclein

Brain Research

Volumn 1542, Issue , 2014, Pages 186-194

  Takano, Mariko ^a   Tashiro, Erika ^a   Kitamura, Akira ^a   Maita, Hiroshi ^a   Iguchi Ariga, Sanae M M ^a   Kinjo, Masataka ^a   Ariga, Hiroyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cell death; Chaperone; Prefoldin; Protein aggregation; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; CHAPERONE; GREEN FLUORESCENT PROTEIN; HUNTINGTIN; MUTANT PROTEIN; POLYPEPTIDE; PREFOLDIN; PREFOLDIN 1; PREFOLDIN 2; PREFOLDIN 3; PREFOLDIN 4; PREFOLDIN 5; PREFOLDIN 6; RED FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL CELL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; FLUORESCENCE; GENETIC TRANSFECTION; HUNTINGTON CHOREA; LYSOSOME; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SUBUNIT; UBIQUITINATION; WILD TYPE;

ALPHA-SYNUCLEIN; CELL DEATH; CELL LINE, TUMOR; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MOLECULAR CHAPERONES; MUTATION; NEUROBLASTOMA; RNA, SMALL INTERFERING; TRANSFECTION; UBIQUITIN;

EID: 84890804968     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.10.034     Document Type: Article

References (46)

1. A. Abe, K. Takahashi-Niki, Y. Takekoshi, T. Shimizu, H. Kitaura, H. Maita, S.M.M Iguchi-Ariga, and H. Ariga Prefoldin plays a role as a clearance factor in preventing proteasome inhibitor-induced protein aggregation J. Biol. Chem. 288 2013 27764 27776
2. H. Ariga, K. Takahashi-Niki, I. Kato, H. Maita, T. Niki, and S.M.M. Iguchi-Ariga Neuroprotective function of DJ-1 in Parkinson's disease Oxid. Med. Cell. Longev. 2013 2013 683920
3. C. Behrends, C.A. Langer, R. Boteva, U.M. Böttcher, M.J. Stemp, G. Schaffar, B.V. Rao, A. Giese, H. Kretzschmar, K. Siegers, and F.U. Hartl Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers Mol. Cell 23 2006 887 897
4. S.A. Broadley, and F.U. Hartl The role of molecular chaperones in human misfolding diseases FEBS Lett. 583 2009 2647 2653
5. A. Chaari, J. Hoarau-Véchot, and M. Ladjimi Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease Int. J. Biol. Macromol. 60 2013 196 205
6. M.C. Chartier-Harlin, J. Kachergus, C. Roumier, V. Mouroux, X. Douay, S. Lincoln, C. Levecque, L. Larvor, J. Andrieux, M. Hulihan, N. Waucquier, L. Defebvre, P. Amouyel, M. Farrer, and A. Destée Alpha-synuclein locus duplication as a cause of familial Parkinson's disease Lancet 364 2004 1167 1169
7. D. Chhangani, and A. Mishra Protein quality control system in neurodegeneration: a healing company hard to beat but failure is fatal Mol. Neurobiol. 48 2013 141 156
8. D.K. Clare, and H.R. Saibil ATP-driven molecular chaperone machines Biopolymers 99 2013 846 859
9. E. Cohen Aging, protein aggregation, chaperones, and neurodegenerative disorders: mechanisms of coupling and therapeutic opportunities Rambam Maimonides Med. J. 3 2012 e0021
10. K.A. Conway, J.D. Harper, and P.T. Lansbury Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease Nat. Med. 4 1998 1318 1320
11. D. Ebrahimi-Fakhari, I. Cantuti-Castelvetri, Z. Fan, E. Rockenstein, E. Masliah, B.T. Hyman, P.J. McLean, and V.K. Unni Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein J. Neurosci. 31 2011 14508 14520
12. C.G. Evans, S. Wisén, and J.E. Gestwicki Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro J. Biol. Chem. 281 2006 33182 33191
13. S. Geissler, K. Siegers, and E. Schiebel A novel protein complex promoting formation of functional alpha- and gamma-tubulin EMBO J. 17 1998 952 966
14. F.U. Hartl, and M. Hayer-Hartl Molecular chaperones in the cytosol: from nascent chain to folded protein Science 295 2002 1852 1858
15. D.N. Hauser, and T.G. Hastings Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism Neurobiol. Dis. 51 2013 35 42
16. P. Ibáñez, A.M. Bonnet, B. Débarges, E. Lohmann, F. Tison, P. Pollak, Y. Agid, A. Dürr, and A. Brice Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease Lancet 364 2004 1169 1171
17. P. Kazemi-Esfarjani, and S. Benzer Genetic suppression of polyglutamine toxicity in Drosophila Science 287 2000 1837 1840
18. Y.E. Kim, M.S. Hipp, A. Bracher, M. Hayer-Hartl, and F.U. Hartl Molecular chaperone functions in protein folding and proteostasis Annu. Rev. Biochem. 82 2013 323 355
19. A. Kitamura, H. Kubota, C.G. Pack, G. Matsumoto, S. Hirayama, Y. Takahashi, H. Kimura, M. Kinjo, R.I. Morimoto, and K. Nagata Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state Nat. Cell Biol. 8 2006 1163 1170
20. J. Klucken, Y. Shin, E. Masliah, B.T. Hyman, and P.J. McLean Hsp70 reduces alpha-synuclein aggregation and toxicity J. Biol. Chem. 279 2004 25497 25502
21. R. Krüger, W. Kuhn, T. Müller, D. Woitalla, M. Graeber, S. Kösel, H. Przuntek, J.T. Epplen, L. Schöls, and O. Riess Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat. Genet. 18 1998 106 108
22. E. Liani, A. Eyal, E. Avraham, R. Shemer, R. Szargel, D. Berg, A. Bornemann, O. Riess, C.A. Ross, R. Rott, and S. Engelender Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease Proc. Natl. Acad. Sci. USA 101 2004 5500 5505
23. J. Martín-Benito, J. Gómez-Reino, P.C. Stirling, V.F. Lundin, P. Gómez-Puertas, J. Boskovic, P. Chacón, J.J. Fernández, J. Berenguer, M.R. Leroux, and J.M. Valpuesta Divergent substrate-binding mechanisms reveal an evolutionary specialization of eukaryotic prefoldin compared to its archaeal counterpart Structure 15 2007 101 110
24. E.M. Merzlyak, J. Goedhart, D. Shcherbo, M.E. Bulina, A.S. Shcheglov, A.F. Fradkov, A. Gaintzeva, K.A. Lukyanov, S. Lukyanov, T.W. Gadella, and D.M. Chudakov Bright monomeric red fluorescent protein with an extended fluorescence lifetime Nat. Methods 4 2007 555 557
25. M. Miyazawa, E. Tashiro, H. Kitaura, H. Maita, H. Suto, S.M.M Iguchi-Ariga, and H. Ariga Prefoldin subunits are protected from ubiquitin-proteasome system-mediated degradation by forming complex with other constituent subunits J. Biol. Chem. 286 2011 19191 19203
26. R.I. Morimoto Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging Genes Dev. 22 2008 1427 3148
27. P.J. Muchowski, G. Schaffar, A. Sittler, E.E. Wanker, M.K. Hayer-Hartl, and F.U. Hartl Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils Proc. Natl. Acad. Sci. USA 97 2000 7841 7846
28. L. Narhi, S.J. Wood, S. Steavenson, Y. Jiang, G.M. Wu, D. Anafi, S.A. Kaufman, F. Martin, K. Sitney, P. Denis, J.C. Louis, J. Wypych, A.L. Biere, and M. Citron Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation J. Biol. Chem. 274 1999 9843 9846
29. R.A. Nixon The role of autophagy in neurodegenerative disease Nat. Med. 19 2013 983 997
30. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
31. Y. Sai, Z. Zou, K. Peng, and Z. Dong The Parkinson's disease-related genes act in mitochondrial homeostasis Neurosci. Biobehav. Rev. 36 2012 2034 2043
32. M. Sakono, T. Zako, H. Ueda, M. Yohda, and M. Maeda Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin FEBS J. 275 2008 5982 5993
33. K. Siegers, T. Waldmann, M.R. Leroux, K. Grein, A. Shevchenko, E. Schiebel, and F.U. Hartl Compartmentation of protein folding in vivo: sequestration of non-native polypeptide by the chaperonin-GimC system EMBO J. 18 1999 75 84
34. R. Siegert, M.R. Leroux, C. Scheufler, F.U. Hartl, and I. Moarefi Structure of the molecular chaperone prefoldin: unique interaction of multiple coiled coil tentacles with unfolded proteins Cell 103 2000 621 632
35. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nussbaum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, M.R. Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy, and K. Gwinn-Hardy alpha-Synuclein locus triplication causes Parkinson's disease Science 302 2003 841
36. B. Spencer, R. Potkar, M. Trejo, E. Rockenstein, C. Patrick, R. Gindi, A. Adame, T. Wyss-Coray, and E. Masliah Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases J. Neurosci. 29 2009 13578 13588
37. K.M. Sörgjerd, T. Zako, M. Sakono, P.C. Stirling, M.R. Leroux, T. Saito, P. Nilsson, M. Sekimoto, T.C. Saido, and M. Maeda Human prefoldin inhibits amyloid-β (Aβ) fibrillation and contributes to formation of nontoxic Aβ aggregates Biochemistry 52 2013 3532 3542
38. M. Takalo, A. Salminen, H. Soininen, M. Hiltunen, and A. Haapasalo Protein aggregation and degradation mechanisms in neurodegenerative diseases Am. J. Neurodegener. Dis. 2 2013 1 14
39. S. Tam, R. Geller, C. Spiess, and J. Frydman The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions Nat. Cell Biol. 8 2006 1155 1162
40. E. Tashiro, T. Zako, H. Muto, Y. Itoo, K. Sörgjerd, N. Terada, A. Abe, M. Miyazawa, A. Kitamura, H. Kitaura, H. Kubota, M. Maeda, T. Momoi, S.M.M. Iguchi-Ariga, M. Kinjo, and H. Ariga Prefoldin protects neuronal cells from polyglutamine toxicity by preventing aggregation formation J. Biol. Chem. 288 2013 19958 19972
41. I.E. Vainberg, S.A. Lewis, H. Rommelaere, C. Ampe, J. Vandekerckhove, H.L. Klein, and N.J. Cowan Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin Cell 93 1998 863 873
42. J.L. Wacker, M.H. Zareie, H. Fong, M. Sarikaya, and P.J. Muchowski Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer Nat. Struct. Mol. Biol. 11 2004 1215 1222
43. J.M. Warrick, H.Y. Chan, G.L. Gray-Board, Y. Chai, H.L. Paulson, and N.M. Bonini Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 Nat. Genet. 23 1999 425 428
44. B. Winner, R. Jappelli, S.K. Maji, P.A. Desplats, L. Boyer, S. Aigner, C. Hetzer, T. Loher, M. Vilar, S. Campioni, C. Tzitzilonis, A. Soragni, S. Jessberger, H. Mira, A. Consiglio, E. Pham, E. Masliah, F.H. Gage, and R. Riek In vivo demonstration that alpha-synuclein oligomers are toxic Proc. Natl. Acad. Sci. USA 108 2011 4194 4199
45. W.H. Yu, B. Dorado, H.Y. Figueroa, L. Wang, E. Planel, M.R. Cookson, L.N. Clark, and K.E. Duff Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein Am. J. Pathol. 175 2009 736 747
46. J.J. Zarranz, J. Alegre, J.C. Gómez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atarés, V. Llorens, E. Gomez Tortosa, T. del Ser, D.G. Muñoz, and J.G. de Yebenes The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164 173